Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.186 EUR | -1.17% | -4.35% | -35.86% |
Business Summary
Number of employees: 105
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Epicutaneous Immunotherapy Products
100.0
%
| 5 | 100.0 % | 15 | 100.0 % | +215.64% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
France
100.0
%
| 5 | 100.0 % | 15 | 100.0 % | +215.64% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Daniel Tassé
CEO | Chief Executive Officer | 64 | 28/11/18 |
Director of Finance/CFO | 54 | 11-05 | |
Pharis Mohideen
CTO | Chief Tech/Sci/R&D Officer | 59 | 21/07/19 |
Pascale Ehouarn
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/05 |
Katie Matthews
IRC | Investor Relations Contact | - | - |
Pascal Wotling
PRN | Corporate Officer/Principal | - | 31/03/20 |
General Counsel | - | 21/02/21 | |
Caroline Daniere
HRO | Human Resources Officer | 50 | 01/09/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Morris
BRD | Director/Board Member | 61 | 28/02/21 |
Michel de Rosen
CHM | Chairman | 73 | 21/06/18 |
Don Soland
BRD | Director/Board Member | 65 | 05/03/15 |
Michael Goller
BRD | Director/Board Member | 49 | 20/10/15 |
Daniel Tassé
CEO | Chief Executive Officer | 64 | 28/11/18 |
Maïlys Ferrère
BRD | Director/Board Member | 60 | 20/06/16 |
Director/Board Member | 64 | 02/10/22 | |
Julie O'Neill
BRD | Director/Board Member | 58 | 14/06/17 |
Ravi Rao
BRD | Director/Board Member | 55 | 18/05/21 |
Adora Ndu
BRD | Director/Board Member | 43 | 18/05/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 96,250,954 | 86,727,703 ( 90.11 %) | 149,793 ( 0.1556 %) | 90.11 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
DBV TECHNOLOGIES 0.16% | 149,793 | 0.16% | 215,324 $ |
Company contact information
DBV Technologies SA
177-181, avenue Pierre Brossolette
92120, Montrouge
+33 1 55 42 78 78
http://www.dbv-technologies.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.86% | 122M | |
+5.31% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
+18.82% | 2.38B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B |
- Stock Market
- Equities
- DBV Stock
- Company DBV Technologies